Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17*
By S. Aggarwal, N. Ghilardi, M. Xie, F. D. de Sauvage, A. Gurney. 2003
2,050 citations recorded by the source corpus.
Interleukin (IL)-17 is a pro-inflammatory cytokine that is produced by activated T cells. Despite increasing evidence that high levels of IL-17 are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis, and multiple sclerosis, the regulation of its expression is not well characterized. We observe that IL-17 production is increased in response to the recently described cytokine IL-23. We present evidence that murine IL-23, which is produced by activated dendritic cells, acts on memory T cells, resulting in elevated IL-17 secretion. IL-23 also induced expression of the related cytokine IL-17F. IL-23 is a heterodimeric cytokine and shares a subunit, p40, with IL-12. In contrast to IL-23, IL-12 had only marginal effects on IL-17 production. These data suggest that during a secondary immune response, IL-23 can promote an activation state with features distinct from the well characterized Th1 and Th2 profiles.
Subfields: Dermatology, Immunology, Pathology and Forensic Medicine
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Dermatology
In Immunology
In Pathology and Forensic Medicine
Citations in the corpus
- IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. (2006, background): “also noted that not all IL-17 production is abrogated in the absence of IL-23 (37).”
- IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses (2013, background): “IL-23 is a crucial cytokine for the induction of Th17 cells at mucosal sites such as the lung and the SI (Aggarwal et al., 2003; Ahern et al., 2010).”
- IL-17 family cytokines and the expanding diversity of effector T cell lineages. (2007, methodology): “Consistent with the previous identification of induction of IL-17A by IL-23 (71) was the finding that mice deficient in IL-23 lost development of a population of an IL17-expressing subset of CD4 T cells, while retaining IFN-γ-producing, Th1-type cells.”
- Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 (2007, background): “and that IL-23 acts secondarily to support the proliferation and differentiation of T H -17 cell”
- Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation (2003, background): “Our ongoing studies, as well as recent published work (22), indicate that mouse IL-23 does not induce IFN- production in T cells, but rather induces TNF and IL-17 (see the IL-23 Promotes the Development.”
- IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis (2006, background): “IL-23 is a potent regulator of memory T cell development and/or expansion that is skewed to IL-17A secretion (36), and IL-23 has been implicated as a key disease driver in autoimmune disease models (13, 23).”
- Th17 cells in human disease (2008, background): “However, subsequent studies demonstrated that the IL-23 receptor is only expressed on T cells after activation, and therefore IL-23 can upregulate IL-17 in memory T cells but cannot act on naı̈ve T cells to induce Th17 differentiation (9).”
- Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease (2008, background): “In mice, IL-23 was once thought to control Th17 differentiation, but it now appears that its role is in survival and expansion of Th17 cells (Aggarwal et al., 2003; Cua et al., 2003; Veldhoen et al., 2006).”
- TH-17 cells in the circle of immunity and autoimmunity (2007, background): “T H -17 cell differentiation Initial studies suggested that IL-23 induces the differentiation of T H -17 cell”
- Signaling by IL‐12 and IL‐23 and the immunoregulatory roles of STAT4 (2004, background): “It has been reported additionally that in murine CD4þ T cells, the major role of IL-23 is as a potent inducer of the proinflammatory cytokine IL-17 (142).”
- Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris (2004, background): “Expression of IL-23 may also drive increased production of IL-17 in affected skin (20).”
- IL-17-Mediated Regulation of Innate and Acquired Immune Response against Pulmonary Mycobacterium bovis Bacille Calmette-Guérin Infection1 (2007, background): “Instead, IL-23 (but not IL-12) induces the proliferation of memory CD4 T cells and the IL-17 production of CD4 T cells (29, 28, 31).”